We are live on !
Find out more
Freestone Grove Partners Portfolio holdings
AUM
$15.6B
Turnover
60.27%
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter Est. Return
+14.49%
1 Year Est. Return
+27.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.6B
AUM Growth
+$1.42B
(+10%)
Cap. Flow
+$81.1M
Cap. Flow % of AUM
Cap. Flow %
0.52%
Top 10 Holdings %
Top 10 Hldgs %
22.3%
Holding
1,397
New
435
Increased
253
Reduced
266
Closed
407
Avg Time Held
Equity + Options
0.3
years
Top 10 Avg Time Held
Equity + Options
0.2
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.3
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$311M |
| 2 |
Abbott
ABT
|
+$125M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$121M |
| 4 |
SpaceX
SPCX
|
+$116M |
| 5 |
Procter & Gamble
PG
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Datadog
DDOG
|
+$128M |
| 2 |
Pinnacle Financial Partners Inc
PNFP
|
+$111M |
| 3 |
Elastic
ESTC
|
+$110M |
| 4 |
Twilio
TWLO
|
+$110M |
| 5 |
Intuitive Surgical
ISRG
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.5% |
| 2 | Financials | 16.81% |
| 3 | Miscellaneous | 15.64% |
| 4 | Technology | 13.57% |
| 5 | Healthcare | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
401
Teledyne Technologies
TDY
$28.4B
| $2.4M | 0.02% |
+3,605
| New | +$2.27M |
2026 Q2
0 quarters
|
|
402
National Health Investors
NHI
$3.25B
| $2.34M | 0.02% |
30,673
-227,350
| -88% | -$17.4M |
2025 Q4
2 quarters
|
|
403
FTI Consulting
FCN
$4.3B
| $2.33M | 0.01% |
+15,621
| New | +$2.56M |
2026 Q2
0 quarters
|
|
404
Annaly Capital Management
NLY
$13.9B
| $2.32M | 0.01% |
+103,892
| New | +$2.29M |
2026 Q2
0 quarters
|
|
405
Mid-America Apartment Communities
MAA
$14B
| $2.32M | 0.01% |
16,693
-98,679
| -86% | -$12.9M |
2026 Q1
1 quarter
|
|
406
Comcast
CMCSA
$81.1B
| $2.3M | 0.01% |
93,705
-15,024
| -14% | -$388K |
2026 Q1
1 quarter
|
|
407
Universal Health Services
UHS
$10.9B
| $2.29M | 0.01% |
+15,397
| New | +$2.5M |
2026 Q2
0 quarters
|
|
408
Maximus
MMS
$3.34B
| $2.22M | 0.01% |
41,332
+32,359
| +361% | +$2.02M |
2025 Q4
2 quarters
|
|
409
Alliant Energy
LNT
$18B
| $2.21M | 0.01% |
28,987
-135,610
| -82% | -$9.9M |
2025 Q1
5 quarters
|
|
410
AGNC Investment
AGNC
$10.6B
| $2.2M | 0.01% |
+201,433
| New | +$2.12M |
2026 Q2
0 quarters
|
|
411
Factset
FDS
$12B
| $2.18M | 0.01% |
+9,470
| New | +$2.17M |
2026 Q2
0 quarters
|
|
412
Brunswick
BC
$4.37B
| $2.16M | 0.01% |
25,623
+625
| +3% | +$50.1K |
2026 Q1
1 quarter
|
|
413
Crown Castle
CCI
$33.7B
| $2.14M | 0.01% |
28,241
+12,759
| +82% | +$1.12M |
2026 Q1
1 quarter
|
|
414
The Marzetti Company
MZTI
$3B
| $2.13M | 0.01% |
18,693
+3,138
| +20% | +$377K |
2026 Q1
1 quarter
|
|
415
Oruka Therapeutics
ORKA
$5.38B
| $2.13M | 0.01% |
+22,421
| New | +$1.49M |
2026 Q2
0 quarters
|
|
416
Kirby Corp
KEX
$6.97B
| $2.1M | 0.01% |
15,480
+15,458
| +70,264% | +$2.21M |
2026 Q1
1 quarter
|
|
417
Travel + Leisure Co
TNL
$4.11B
| $2.08M | 0.01% |
27,199
+824
| +3% | +$57.9K |
2026 Q1
1 quarter
|
|
418
Exponent
EXPO
$3.61B
| $2.08M | 0.01% |
35,346
+23,421
| +196% | +$1.44M |
2026 Q1
1 quarter
|
|
419
Arxis Inc
ARXS
$21B
| $2.08M | 0.01% |
+45,000
| New | +$1.76M |
2026 Q2
0 quarters
|
|
420
Kulicke & Soffa
KLIC
$3.91B
| $2.03M | 0.01% |
15,201
+7,544
| +99% | +$739K |
2025 Q1
5 quarters
|
|
421
Spyre Therapeutics
SYRE
$8.65B
| $2.02M | 0.01% |
+22,777
| New | +$1.66M |
2026 Q2
0 quarters
|
|
422
Winnebago Industries
WGO
$777M
| $2.02M | 0.01% |
64,671
+52,133
| +416% | +$1.59M |
2026 Q1
1 quarter
|
|
423
Reliance Steel & Aluminium
RS
$21.6B
| $2M | 0.01% |
5,357
+1,574
| +42% | +$575K |
2025 Q2
4 quarters
|
|
424
West Pharmaceutical
WST
$27.7B
| $2M | 0.01% |
5,570
+5,478
| +5,954% | +$1.67M |
2025 Q1
5 quarters
|
|
425
Westlake Corp
WLK
$7.95B
| $1.99M | 0.01% |
+27,248
| New | +$2.66M |
2026 Q2
0 quarters
|
|
Similar funds
Freestone Grove Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Freestone Grove Partners held 1,397 positions worth $15.6B, up 10% from $14.2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Freestone Grove Partners's Q2 2026 filing shows 435 new, 253 increased, 266 reduced and 407 closed positions. Its largest new stake was Abbott: 1,372,846 shares worth $125M. The largest sale was Datadog, an estimated $128M.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 12% a quarter earlier, followed by Financials and Miscellaneous.
- Freestone Grove Partners's largest Q2 2026 buy was Abbott: 1,372,846 shares worth $125M.
- Freestone Grove Partners added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $311M increase.
- Freestone Grove Partners's biggest Q2 2026 reduction was Elastic, cutting an estimated $110M.
- Freestone Grove Partners fully exited Datadog in Q2 2026, selling an estimated $128M.
- Freestone Grove Partners's ten largest holdings make up 22% of its $15.6B portfolio in Q2 2026.
- Freestone Grove Partners opened 435 new positions and closed 407 in Q2 2026.
- Freestone Grove Partners's portfolio value rose 10% quarter-over-quarter to $15.6B.
Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.